Title: Risk of Retinopathy in Relation To Diabetic Patients

Authors: Nandhini.S, Dr Naufal Rizwan

 DOI:  http://dx.doi.org/10.18535/jmscr/v4i8.47

Abstract

AIM- The aim of this article is to prove the incidence of retinopathy in patients with diabetes

OBJECTIVE- Diabetic retinopathy is the most frequent cause of blindness in many patients in the recent studies. Vision loss due to retinopathy occurs due to various reasons.

METHODOLOGY- 50 diabetic patients in Saveetha medical college are examined and results are concluded.

BACKGROUND- Frequently retinopathy is the ocular manifestation of systemic disease as seen in diabetes. The prevalence of retinopathy is being checked by an ophthalmologist during examination and the results are proved.

KEYWORDS – diabetic, blindness, retina.

References

 

1.      Wong TY, Mwamburi M, Klein R, Larsen M, Flynn H, Hernandez-Medina M, Ranganathan G, Wirostko B, Pleil A, Mitchell P. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009 Dec;32 (12): 2307-13.

2.      Jeganathan VS, Wang JJ, Wong TY. Ocular associations of diabetes other than diabetic retinopathy.Diabetes Care. 2008 Sep;31(9):1905-12.

3.      Diabetes control and complications trial. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995 Aug;44(8):968- 83.

4.      UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53.

5.      Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006 Aug; 49(8):1761-9. Epub 2006 May 31.

6.      Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM; UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004 Nov;122(11):1631-40.

7.      ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, DanisRP,Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC,Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010 Jul 15;363(3):233-44. Epub 2010 Jun 29.

Corresponding Author

Nandhini.S

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.